The Health Care Select Sector SPDR Fund ETF ( NYSEARCA: XLV) rose nearly 4% in the week, outpacing the broader markets. On a ...

Shares of Hikma Pharmaceuticals PLC HIK slid 1.18% to £20.04 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.20% to 9,120.31 ...

Hikma Pharmaceuticals PLC closed 14.07% short of its 52-week high of £23.60, which the company reached on February 13th.

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their top priorities for the rest of 2025. The 12 executives featured in this article are all speaking at ...

So let's assess the underlying fundamentals over the last 3 years and see if they've moved in lock-step with shareholder returns. This technology could replace computers: discover the 20 stocks are ...

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

Oregon will receive $10.1 million for drug prevention and treatment services as part of a nationwide settlement with eight ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates ...

New Hampshire will receive $4.5 million over the next 10 years as part of a nationwide opioid settlement involving eight drug companies.

SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board of Directors granted ...

FOSTER CITY, Calif.-- (BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on July 10, 2025, the Compensation Committee of Mirum’s Board of Directors granted inducement ...

Today’s settlement brings in millions of dollars to help Utah heal from this epidemic and ensures families see the justice they deserve,' Utah Attorney General Derek Brown said.